Gilead Sciences reports promising early results in COVID-19 trial using remdesivir
3:54am PDT - April 29th, 2020 remdesivir - The Washington TimesA drug developed by Gilead Sciences is showing promise in the fight against COVID-19, with a government study indicating remdesivir has a "clear-cut" effect in cutting the time patients need to recover.